title: Poorly differentiated Sertoli-Leydig tumor with heterologous, high-grade, sarcomatoid features: A case report.
abstract: •Treatment of sex-cord stromal tumors with carboplatin and taxane is both feasible and safe.•FOXL2 mutations account for approximately 50% of these tumors.•Carboplatin and taxane may afford a favorable outcome.
authors.affiliation: Department of Gynecologic Oncology,Roswell Park Cancer InstituteBuffalo,NY, USA.
authors.forename: Rachel
authors.initials: R
authors.lastname: Brightwell
authors.affiliation: Department of Gynecologic Oncology,Roswell Park Cancer InstituteBuffalo,NY, USA.
authors.forename: Kassondra
authors.initials: K
authors.lastname: Grzankowski
authors.affiliation: Department of Pathology,Roswell Park Cancer Institute,Buffalo,NY, USA.
authors.forename: John
authors.initials: J
authors.lastname: Kasznica
authors.affiliation: Department of Gynecologic Oncology,Roswell Park Cancer InstituteBuffalo,NY, USA.
authors.forename: Peter J
authors.initials: PJ
authors.lastname: Frederick
keywords: Heterologous; Ovarian; Sarcomatoid; Sertoli–Leydig